GSE165960 MEK inhibition 2 v 6 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE165960_MEK inhibition_2_v_6_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE165960_MEK inhibition_2_v_6_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE165960_MEK inhibition_2_v_6_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE165960_MEK inhibition_2_v_6_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

H19 imprinted maternally expressed transcript

Gene

small integral membrane protein 48

Gene

PARD6G antisense RNA 1

Gene

SLCO5A1 antisense RNA 1

Gene

small Cajal body-specific RNA 2

Gene

MIR378D2 host gene

Gene

long intergenic non-protein coding RNA 3064

Gene

chaperonin containing TCP1 subunit 5 pseudogene 1

Gene

RNA, 7SL, cytoplasmic 19, pseudogene

Gene

Putative uncharacterized protein FLJ39060

  • Gene

    H19 imprinted maternally expressed transcript


  • Gene

    small integral membrane protein 48


  • Gene

    PARD6G antisense RNA 1


  • Gene

    SLCO5A1 antisense RNA 1


  • Gene

    small Cajal body-specific RNA 2



  • Gene

    long intergenic non-protein coding RNA 3064


  • Gene

    chaperonin containing TCP1 subunit 5 pseudogene 1


  • Gene

    RNA, 7SL, cytoplasmic 19, pseudogene


  • Gene

    Putative uncharacterized protein FLJ39060

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.